(Finance) – Kolinpharmaa company operating in the nutraceutical sector and listed on the Euronext Growth Milan market, announced that in the third quarter of 2022 number of medical prescriptions amounted to 185,122, up by 13.1% compared to 163,727 in the third quarter of 2021 and up by 16.8% in terms of values compared to the same period of 2021. In the first 9 months of 2022 total number of medical prescriptions stood at 559,868, up by 18.3% compared to 473,398 in the first 9 months of 2021.
As of 30 September 2022 the number of Medical Scientific Representatives (IMS) it is 80, compared to 89 in the previous quarter and compared to 85 IMS at 30 September 2021.
“The third quarter of 2022 closes positively, confirming double-digit growth both in terms of values and volumes of medical prescriptions – commented the president Rita Paola Petrelli – The Company’s development activities continued, both in the product and scientific research and in the commercial field, as also confirmed by the recent agreement signed with AstaReal AB which will allow us to start sales in China, Hong Kong, Macao and Taiwan “.